
|Articles|August 1, 2003
Use of TNF Inhibitors: The Changing Treatment Paradigm
Author(s)Mark G. Lebwohl, MD
Current therapies for psoriasis can be very effective and are acceptable to many patients. However, a number of drawbacks associated with these treatments may compromise their effectiveness. Patients undergoing ultraviolet B (UVB) phototherapy or psoralen plus ultraviolet A (PUVA) treatments must keep their appointments 3 times a week to maintain the effectiveness of the therapy.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Harrison Nguyen, MD, MBA, MPH’s Deep Dive into CSU, Vasculitis, and Autoimmune Blisters
2
From TikTok to Targeted Therapy: Shannon Trotter, DO, on Modern Dermatology Challenges
3
Derm Dispatch: SDPA President-Elect Andrew Baker, MBA, MPAS, PA-C, Shares His Vision
4
Derm Dispatch at SDPA Fall 2025: How a New Initiative Will Transform Dermatologic Health Through Nutrition
5



















